Skip to product information
1 of 1

PerCP-Cy5.5 Armenian hamster Anti-Human/Mouse/Rat CD278 Antibody (S-R578)

PerCP-Cy5.5 Armenian hamster Anti-Human/Mouse/Rat CD278 Antibody (S-R578)

Catalog Number: S0B8010 Application: FCM Reactivity: Human Conjugation: PerCP-Cy5.5 Brand: Starter
Price:
Regular price $92.00 SGD
Regular price Sale price $92.00 SGD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Armenian hamster
Antigen CD278
Synonyms Inducible T-cell costimulator; Activation-inducible lymphocyte immunomediatory molecule; AILIM; ICOS
Location Cell membrane
Accession Q9Y6W8
Clone Number S-R578
Antibody Type Recombinant mAb
Isotype IgG
Application FCM
Reactivity Hu
Positive Sample ConA treated C57BL/6 mouse splenocytes
Purification Protein G
Concentration 0.2 mg/ml
Conjugation PerCP-Cy5.5
Physical Appearance Liquid
Storage Buffer

PBS, 1% BSA, 0.3% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

Dilution


application dilution species
FCM 5μl per million cells in 100μl volume Hu, Ms, Rt

Background

CD278, also known as ICOS (Inducible T-cell Costimulator), is a type I transmembrane glycoprotein that belongs to the CD28 family of costimulatory immunoreceptors. It is expressed on the surface of activated T cells, including cytotoxic T cells, regulatory T cells (Tregs), and other types of T cells. Its ligand, ICOSL (B7-H2 or CD275), is found on antigen-presenting cells (APCs) such as dendritic cells and macrophages, as well as on B cells. ICOS functions as a homodimer and plays a crucial role in cell-cell signaling, immune responses, and the regulation of cell proliferation. The interaction between ICOS and ICOSL enhances T-cell activation, proliferation, and differentiation, and is essential for the development of follicular helper T cells (Tfh) and efficient B-cell antibody responses. ICOS has also been implicated in various disorders, including immunodeficiency and autoimmune diseases. In cancer immunotherapy, ICOS expression has been identified as a potential predictive biomarker for responses to checkpoint inhibitor treatments.

Picture

FC

Flow cytometric analysis of C57BL/6 mouse splenocytes were stained with stimulated 3 days with 2.5 μg/ml ConA (Right panel) or unstimulated (Left panel) was stained with Brilliant Violet 421™ Mouse Anti-Human CD3 and Percp-Cy5.5 Armenian hamster Anti- Human/Mouse/Rat CD278 Antibody at 5 μl/test treated with True-Stain Monocyte Blocker™. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.